Results of lung transplantation;Résultats de la transplantation pulmonaire

Revue des Maladies Respiratoires

Volumn 27, Issue 8, 2010, Pages 921-938

  Quetant S ^a,b,c   Rochat, T ^d   Pison, C ^a,b,c  

^a GRENOBLE UNIVERSITY HOSPITAL   (France)

^b INSERM   (France)

^c UNIV GRENOBLE ALPES   (France)

^d UNIVERSITY OF GENEVA   (Switzerland)

Author keywords

Cost effectiveness; Lung transplantation; Quality of life related to health; Results; Survival

Indexed keywords

CHRONIC OBSTRUCTIVE LUNG DISEASE; COST EFFECTIVENESS ANALYSIS; CYSTIC FIBROSIS; FRANCE; HUMAN; INTERSTITIAL LUNG DISEASE; LUNG FIBROSIS; LUNG FUNCTION; LUNG TRANSPLANTATION; PULMONARY HYPERTENSION; QUALITY OF LIFE; REVIEW; SURVIVAL;

EID: 78649666323     PISSN: 07618425     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.rmr.2010.08.001     Document Type: Review

References (145)

1. Trulock EP. Lung transplantation. Am J Respir Crit Care Med 1997;155:789-818.
2. Arcasoy SM, Kotloff RM. Lung transplantation. N Engl J Med 1999;340:1081-91.
3. Hertz MI, Aurora P, Christie JD, Dobbels F, Edwards LB, Kirk R, et al. Registry of the International Society for Heart and Lung Transplantation: a quarter century of thoracic transplantation. J Heart Lung Transplant 2008;27:937-42.
4. Orens JB, Garrity Jr ER. General overview of lung transplantation and review of organ allocation. Proc Am Thorac Soc 2009;6:13-9.
5. Despins P. Update in lung transplantation, 2008. Rev Mal Respir 2008;25:915-6.
6. Stern M, Souilamas R, Tixier D, Mal H. Lung transplantation: supply and demand in France. Rev Mal Respir 2008;25:953-65.
7. Reynaud-Gaubert M, Boniface S, Metivier AC, Kessler R. When should patients be referred by the physician to the lung transplant team? Patient selection, indications, timing of referral and preparation for lung transplantation. Rev Mal Respir 2008;25:1251-9.
8. Mal H, Thabut G, Evrard P. When should the pulmonologist consider lung transplantation? Criteria for referral and transplantation in COPD and idiopathic pulmonary fibrosis. Rev Mal Respir 2009;26:183-90.
9. Philippe B, Dromer C, Mornex JF, Velly JF, Stern M. When should respiratory physicians consider lung transplantation for their patients? Inscription criteria for the National Waiting List. Rev Mal Respir 2009;26:423-35.
10. Yusen RD. Technology and outcomes assessment in lung transplantation. Proc Am Thorac Soc 2009;6:128-36.
11. Toronto Lung Transplant Group. Unilateral lung transplantation for pulmonary fibrosis. N Engl J Med 1986;314:1140-5.
12. Reitz BA, Wallwork JL, Hunt SA, Pennock JL, Billingham ME, Oyer PE, et al. Heart-lung transplantation: successful therapy for patients with pulmonary vascular disease. N Engl J Med 1982;306:557-64.
13. Christie JD, Edwards LB, Aurora P, Dobbels F, Kirk R, Rahmel AO, et al. Registry of the International Society for Heart and Lung Transplantation: twenty-fifth official adult lung and heart/lung transplantation report - 2008. J Heart Lung Transplant 2008;27:957-69.
14. Agence, BioMédecine D. Bilan des activités de prélèvement et de greffe en France en 2007. Greffe pulmonaire et cardiopulmonaire 2007:63-82.
15. O'Sullivan BP, Freedman SD. Cystic fibrosis. Lancet 2009;373:1891-904.
16. Reynaud-Gaubert M, Mornex JF, Mal H, Treilhaud M, Dromer C, Quetant S, et al. Lung transplantation for lymphangioleiomyomatosis: the French experience. Transplantation 2008;86:515-20.
17. Van Raemdonck D, Neyrinck A, Verleden GM, Dupont L, Coosemans W, Decaluwe H. Lung donor selection and management. Proc Am Thorac Soc 2009;6:28-38.
18. Boasquevisque CH, Yildirim E, Waddel TK, Keshavjee S. Surgical techniques: lung transplant and lung volume reduction. Proc Am Thorac Soc 2009;6:66-78.
19. Lyu DM, Zamora MR. Medical complications of lung transplantation. Proc Am Thorac Soc 2009;6:101-7.
20. Lee JC, Christie JD. Primary graft dysfunction. Proc Am Thorac Soc 2009;6:39-46.
21. Santacruz JF, Mehta AC. Airway complications and management after lung transplantation: ischemia, dehiscence, and stenosis. Proc Am Thorac Soc 2009;6:79-93.
22. Bhorade SM, Stern E. Immunosuppression for lung transplantation. Proc Am Thorac Soc 2009;6:47-53.
23. Remund KF, Best M, Egan JJ. Infections relevant to lung transplantation. Proc Am Thorac Soc 2009;6:94-100.
24. Belperio JA, Weigt SS, Fishbein MC, Lynch 3rd JP. Chronic lung allograft rejection: mechanisms and therapy. Proc Am Thorac Soc 2009;6:108-21.
25. Hachem RR, Yusen RD, Chakinala MM, Meyers BF, Lynch JP, Aloush AA, et al. A randomized controlled trial of tacrolimus versus cyclosporine after lung transplantation. J Heart Lung Transplant 2007;26:1012-8.
26. Hachem RR, Trulock EP. The new lung allocation system and its impact on waitlist characteristics and post-transplant outcomes. Semin Thorac Cardiovasc Surg 2008;20:139-42.
27. Callahan D. Cost control - Time to be serious. N Engl J Med 2009;361:1.
28. Littenberg B. Technology assessment in medicine. Acad Med 1992;67:424-8.
29. Egan TM, Murray S, Bustami RT, Shearon TH, McCullough KP, Edwards LB, et al. Development of the new lung allocation system in the United States. Am J Transplant 2006;6:1212-27.
30. Thabut G, Fournier M. Assessment of the survival benefit of lung transplantation. Rev Mal Respir 2009;26:139-45.
31. Thabut G, Ravaud P, Christie JD, Castier Y, Fournier M, Mal H, et al. Determinants of the survival benefit of lung transplantation in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2008;177:1156-63.
32. Thabut G, Christie JD, Ravaud P, Castier Y, Brugiere O, Fournier M, et al. Survival after bilateral versus single lung transplantation for patients with chronic obstructive pulmonary disease: a retrospective analysis of registry data. Lancet 2008;371:744-51.
33. Studer SM, Levy RD, McNeil K, Orens JB. Lung transplant outcomes: a review of survival, graft function, physiology, health-related quality of life and cost-effectiveness. Eur Respir J 2004;24:674-85.
34. Orens JB, Estenne M, Arcasoy S, Conte JV, Corris P, Egan JJ, et al. International guidelines for the selection of lung transplant candidates: 2006 update - a consensus report from the Pulmonary Scientific Council of the International Society for Heart and Lung Transplantation. J Heart Lung Transplant 2006;25:745-55.
35. Davis SQ, Garrity Jr ER. Organ allocation in lung transplant. Chest 2007;132:1646-51.
36. Kozower BD, Meyers BF, Smith MA, De Oliveira NC, Cassivi SD, Guthrie TJ, et al. The impact of the lung allocation score on short-term transplantation outcomes: a multicenter study. J Thorac Cardiovasc Surg 2008;135:166-71.
37. McCue JD, Mooney J, Quail J, Arrington A, Herrington C, Dahlberg PS. Ninety-day mortality and major complications are not affected by use of lung allocation score. J Heart Lung Transplant 2008;27:192-6.
38. Liu V, Zamora MR, Dhillon GS, Weill D. Increasing lung allocation scores predict worsened survival among lung transplant recipients. Am J Transplant 2010;10:915-20.
39. Russo MJ, Iribarne A, Hong KN, Davies RR, Xydas S, Takayama H, et al. High lung allocation score is associated with increased morbidity and mortality following transplantation. Chest 2010;137:651-7.
40. Speich R, Nicod LP, Aubert JD, Spiliopoulos A, Wellinger J, Robert JH, et al. Ten years of lung transplantation in Switzerland: results of the Swiss Lung Transplant Registry. Swiss Med Wkly 2004;134:18-23.
41. de Perrot M, Chaparro C, McRae K, Waddell TK, Hadjiliadis D, Singer LG, et al. Twenty-year experience of lung transplantation at a single center: influence of recipient diagnosis on long-term survival. J Thorac Cardiovasc Surg 2004;127:1493-501.
42. Meyers BF, Lynch J, Trulock EP, Guthrie TJ, Cooper JD, Patterson GA. Lung transplantation: a decade of experience. Ann Surg 1999;230:362-70 [discussion 70-1].
43. Burton CM, Milman N, Carlsen J, Arendrup H, Eliasen K, Andersen CB, et al. The Copenhagen National Lung Transplant Group: survival after single lung, double lung, and heart-lung transplantation. J Heart Lung Transplant 2005;24:1834-43.
44. Costache V, Chavanon O, St Raymond C, Sessa C, Durand M, Duret J, et al. Dramatic improvement in survival after lung transplantation over time: a single center experience. Transplant Proc 2009;41:687-91.
45. Meyer DM, Bennett LE, Novick RJ, Hosenpud JD. Single vs bilateral, sequential lung transplantation for end-stage emphysema: influence of recipient age on survival and secondary end-points. J Heart Lung Transplant 2001;20:935-41.
46. Thabut G, Mal H, Castier Y, Groussard O, Brugiere O, Marrash-Chahla R, et al. Survival benefit of lung transplantation for patients with idiopathic pulmonary fibrosis. J Thorac Cardiovasc Surg 2003;126:469-75.
47. Gutierrez C, Al-Faifi S, Chaparro C, Waddell T, Hadjiliadis D, Singer L, et al. The effect of recipient's age on lung transplant outcome. Am J Transplant 2007;7:1271-7.
48. Thabut G, Mal H, Cerrina J, Dartevelle P, Dromer C, Velly JF, et al. Graft ischemic time and outcome of lung transplantation: a multicenter analysis. Am J Respir Crit Care Med 2005;171:786-91.
49. Christie JD, Kotloff RM, Ahya VN, Tino G, Pochettino A, Gaughan C, et al. The effect of primary graft dysfunction on survival after lung transplantation. Am J Respir Crit Care Med 2005;171:1312-6. (Pubitemid 40740741)
50. Brugiere O, Thabut G, Suberbielle C, Reynaud-Gaubert M, Thomas P, Pison C, et al. Relative impact of human leukocyte antigen mismatching and graft ischemic time after lung transplantation. J Heart Lung Transplant 2008;27:628-34.
51. De Perrot M, Waddell TK, Shargall Y, Pierre AF, Fadel E, Uy K, et al. Impact of donors aged 60years or more on outcome after lung transplantation: results of an 11-year single-center experience. J Thorac Cardiovasc Surg 2007;133:525-31.
52. Meyer DM, Bennett LE, Novick RJ, Hosenpud JD. Effect of donor age and ischemic time on intermediate survival and morbidity after lung transplantation. Chest 2000;118:1255-62.
53. Thabut G, Mal H, Cerrina J, Dartevelle P, Dromer C, Velly JF, et al. Influence of donor characteristics on outcome after lung transplantation: a multicenter study. J Heart Lung Transplant 2005;24:1347-53.
54. Hosenpud JD, Bennett LE, Keck BM, Edwards EB, Novick RJ. Effect of diagnosis on survival benefit of lung transplantation for end-stage lung disease. Lancet 1998;351:24-7.
55. Stavem K, Bjortuft O, Borgan O, Geiran O, Boe J. Lung transplantation in patients with chronic obstructive pulmonary disease in a national cohort is without obvious survival benefit. J Heart Lung Transplant 2006;25:75-84.
56. De Meester J, Smits JM, Persijn GG, Haverich A. Listing for lung transplantation: life expectancy and transplant effect, stratified by type of end-stage lung disease, the Eurotransplant experience. J Heart Lung Transplant 2001;20:518-24.
57. Charman SC, Sharples LD, McNeil KD, Wallwork J. Assessment of survival benefit after lung transplantation by patient diagnosis. J Heart Lung Transplant 2002;21:226-32.
58. Patel N, DeCamp M, Criner GJ. Lung transplantation and lung volume reduction surgery versus transplantation in chronic obstructive pulmonary disease. Proc Am Thorac Soc 2008;5:447-53.
59. Patel N, Criner GJ. Transplantation in chronic obstructive pulmonary disease. COPD 2006;3:149-62.
60. Celli BR, Cote CG, Marin JM, Casanova C, Montes de Oca M, Mendez RA, et al. The body-mass index, airflow obstruction, dyspnea, and exercise capacity index in chronic obstructive pulmonary disease. N Engl J Med 2004;350:1005-12.
61. Lahzami S, Bridevaux PO, Soccal PM, Wellinger J, Robert JH, Ris HB, et al. Survival impact of lung transplantation for chronic obstructive pulmonary disease. Eur Respir J 2010;36:74-80.
62. Weill D, Keshavjee S. Lung transplantation for emphysema: two lungs or one. J Heart Lung Transplant 2001;20:739-42.
63. Sundaresan RS, Shiraishi Y, Trulock EP, Manley J, Lynch J, Cooper JD, et al. Single or bilateral lung transplantation for emphysema? J Thorac Cardiovasc Surg 1996;112:1485-94 [discussion 94-5].
64. Cassivi SD, Meyers BF, Battafarano RJ, Guthrie TJ, Trulock EP, Lynch JP, et al. Thirteen-year experience in lung transplantation for emphysema. Ann Thorac Surg 2002;74:1663-9 [discussion 9-70].
65. Hadjiliadis D. Special considerations for patients with cystic fibrosis undergoing lung transplantation. Chest 2007;131:1224-31.
66. Corris PA. Lung transplantation for cystic fibrosis. Curr Opin Organ Transplant 2008;13:484-8.
67. Meachery G, De Soyza A, Nicholson A, Parry G, Hasan A, Tocewicz K, et al. Outcomes of lung transplantation for cystic fibrosis in a large UK cohort. Thorax 2008;63:725-31.
68. Egan TM, Detterbeck FC, Mill MR, Bleiweis MS, Aris R, Paradowski L, et al. Long term results of lung transplantation for cystic fibrosis. Eur J Cardiothorac Surg 2002;22:602-9.
69. Liou TG, Adler FR, Cox DR, Cahill BC. Lung transplantation and survival in children with cystic fibrosis. N Engl J Med 2007;357:2143-52.
70. Hofer M, Benden C, Inci I, Schmid C, Irani S, Speich R, et al. True survival benefit of lung transplantation for cystic fibrosis patients: the Zurich experience. J Heart Lung Transplant 2009;28:334-9.
71. Aurora P, Whitehead B, Wade A, Bowyer J, Whitmore P, Rees PG, et al. Lung transplantation and life extension in children with cystic fibrosis. Lancet 1999;354:1591-3. (Pubitemid 29515950)
72. Sweet SC, Aurora P, Benden C, Wong JY, Goldfarb SB, Elidemir O, et al. Lung transplantation and survival in children with cystic fibrosis: solid statistics-flawed interpretation. Pediatr Transplant 2008;12:129-36.
73. Snell GI, de Hoyos A, Krajden M, Winton T, Maurer JR. Pseudomonas cepacia in lung transplant recipients with cystic fibrosis. Chest 1993;103:466-71.
74. Chaparro C, Maurer J, Gutierrez C, Krajden M, Chan C, Winton T, et al. Infection with Burkholderia cepacia in cystic fibrosis: outcome following lung transplantation. Am J Respir Crit Care Med 2001;163:43-8.
75. Alexander BD, Petzold EW, Reller LB, Palmer SM, Davis RD, Woods CW, et al. Survival after lung transplantation of cystic fibrosis patients infected with Burkholderia cepacia complex. Am J Transplant 2008;8:1025-30.
76. Boussaud V, Guillemain R, Grenet D, Coley N, Souilamas R, Bonnette P, et al. Clinical outcome following lung transplantation in patients with cystic fibrosis colonised with Burkholderia cepacia complex: results from two French centres. Thorax 2008;63:732-7.
77. Murray S, Charbeneau J, Marshall BC, LiPuma JJ. Impact of burkholderia infection on lung transplantation in cystic fibrosis. Am J Respir Crit Care Med 2008;178:363-71.
78. Mal H, Brugiere O, Dauriat G, Groussard O, Valeyre D, Fournier M, et al. Lung transplantation in patients with pulmonary fibrosis. Rev Pneumol Clin 2005;61:232-8.
79. Meyer DM, Edwards LB, Torres F, Jessen ME, Novick RJ. Impact of recipient age and procedure type on survival after lung transplantation for pulmonary fibrosis. Ann Thorac Surg 2005;79:950-7 [discussion 7-8].
80. Trulock EP, Christie JD, Edwards LB, Boucek MM, Aurora P, Taylor DO, et al. Registry of the International Society for Heart and Lung Transplantation: twenty-fourth official adult lung and heart-lung transplantation report - 2007. J Heart Lung Transplant 2007;26:782-95. (Pubitemid 47199080)
81. Meyers BF, Lynch JP, Trulock EP, Guthrie T, Cooper JD, Patterson GA. Single versus bilateral lung transplantation for idiopathic pulmonary fibrosis: a ten-year institutional experience. J Thorac Cardiovasc Surg 2000;120:99-107.
82. Mason DP, Brizzio ME, Alster JM, McNeill AM, Murthy SC, Budev MM, et al. Lung transplantation for idiopathic pulmonary fibrosis. Ann Thorac Surg 2007;84:1121-8.
83. Thabut G, Christie JD, Ravaud P, Castier Y, Dauriat G, Jebrak G, et al. Survival after bilateral versus single-lung transplantation for idiopathic pulmonary fibrosis. Ann Intern Med 2009;151:767-74.
84. Shorr AF, Helman DL, Davies DB, Nathan SD. Sarcoidosis, race, and short-term outcomes following lung transplantation. Chest 2004;125:990-6.
85. Dauriat G, Mal H, Thabut G, Mornex JF, Bertocchi M, Tronc F, et al. Lung transplantation for pulmonary langerhans' cell histiocytosis: a multicenter analysis. Transplantation 2006;81:746-50.
86. Benden C, Rea F, Behr J, Corris PA, Reynaud-Gaubert M, Stern M, et al. Lung transplantation for lymphangioleiomyomatosis: the European experience. J Heart Lung Transplant 2009;28:1-7.
87. Orens JB. Lung transplantation for pulmonary hypertension. Int J Clin Pract Suppl 2007;158:4-9.
88. Toyoda Y, Thacker J, Santos R, Nguyen D, Bhama J, Bermudez C, et al. Long-term outcome of lung and heart-lung transplantation for idiopathic pulmonary arterial hypertension. Ann Thorac Surg 2008;86:1116-22.
89. Franke U, Wiebe K, Harringer W, Franke T, Wittwer T, Wahlers T, et al. Ten years experience with lung and heart-lung transplantation in primary and secondary pulmonary hypertension. Eur J Cardiothorac Surg 2000;18:447-52.
90. Bando K, Armitage JM, Paradis IL, Keenan RJ, Hardesty RL, Konishi H, et al. Indications for and results of single, bilateral, and heart-lung transplantation for pulmonary hypertension. J Thorac Cardiovasc Surg 1994;108:1056-65.
91. Strueber M, Fischer S, Gottlieb J, Simon AR, Goerler H, Gohrbandt B, et al. Long-term outcome after pulmonary retransplantation. J Thorac Cardiovasc Surg 2006;132:407-12.
92. Kawut SM, Lederer DJ, Keshavjee S, Wilt JS, Daly T, D'Ovidio F, et al. Outcomes after lung retransplantation in the modern era. Am J Respir Crit Care Med 2008;177:114-20.
93. Christie JD, Edwards LB, Aurora P, Dobbels F, Kirk R, Rahmel AO, et al. The registry of the International Society for Heart and Lung Transplantation: twenty-sixth official Adult Lung and Heart-Lung Transplantation Report - 2009. J Heart Lung Transplant 2009;28:1031-49.
94. Grossman RF, Frost A, Zamel N, Patterson GA, Cooper JD, Myron PR, et al. Results of single-lung transplantation for bilateral pulmonary fibrosis. The Toronto Lung Transplant Group. N Engl J Med 1990;322:727-33.
95. Orens JB, Becker FS, Lynch JP, 3rd, Christensen PJ, Deeb GM, Martinez FJ. Cardiopulmonary exercise testing following allogeneic lung transplantation for different underlying disease states. Chest 1995;107:144-9.
96. Lands LC, Smountas AA, Mesiano G, Brosseau L, Shennib H, Charbonneau M, et al. Maximal exercise capacity and peripheral skeletal muscle function following lung transplantation. J Heart Lung Transplant 1999;18:113-20.
97. Schwaiblmair M, Reichenspurner H, Muller C, Briegel J, Furst H, Groh J, et al. Cardiopulmonary exercise testing before and after lung and heart-lung transplantation. Am J Respir Crit Care Med 1999;159:1277-83.
98. Levy RD, Ernst P, Levine SM, Shennib H, Anzueto A, Bryan CL, et al. Exercise performance after lung transplantation. J Heart Lung Transplant 1993;12:27-33.
99. Reinsma GD, ten Hacken NH, Grevink RG, van der Bij W, Koeter GH, van Weert E. Limiting factors of exercise performance 1 year after lung transplantation. J Heart Lung Transplant 2006;25:1310-6.
100. Stiebellehner L, Quittan M, End A, Wieselthaler G, Klepetko W, Haber P, et al. Aerobic endurance training program improves exercise performance in lung transplant recipients. Chest 1998;113:906-12.
101. Ambrosino N, Bruschi C, Callegari G, Baiocchi S, Felicetti G, Fracchia C, et al. Time course of exercise capacity, skeletal and respiratory muscle performance after heart-lung transplantation. Eur Respir J 1996;9:1508-14.
102. Skeletal muscle dysfunction in chronic obstructive pulmonary disease. A statement of the American Thoracic Society and European Respiratory Society. Am J Respir Crit Care Med 1999;159: S1-40.
103. Evans AB, Al-Himyary AJ, Hrovat MI, Pappagianopoulos P, Wain JC, Ginns LC, et al. Abnormal skeletal muscle oxidative capacity after lung transplantation by 31P-MRS. Am J Respir Crit Care Med 1997;155:615-21.
104. Guerrero K, Wuyam B, Mezin P, Vivodtzev I, Vendelin M, Borel JC, et al. Functional coupling of adenine nucleotide translocase and mitochondrial creatine kinase is enhanced after exercise training in lung transplant skeletal muscle. Am J Physiol Regul Integr Comp Physiol 2005;289: R1144-54.
105. Sager JS, Kotloff RM, Ahya VN, Hadjiliadis D, Simcox R, Blumenthal NP, et al. Association of clinical risk factors with functional status following lung transplantation. Am J Transplant 2006;6:2191-201.
106. Maury G, Langer D, Verleden G, Dupont L, Gosselink R, Decramer M, et al. Skeletal muscle force and functional exercise tolerance before and after lung transplantation: a cohort study. Am J Transplant 2008;8:1275-81.
107. Dunn SE, Burns JL, Michel RN. Calcineurin is required for skeletal muscle hypertrophy. J Biol Chem 1999;274:21908-12.
108. Zoll J, N'Guessan B, Ribera F, Lampert E, Fortin D, Veksler V, et al. Preserved response of mitochondrial function to shortterm endurance training in skeletal muscle of heart transplant recipients. J Am Coll Cardiol 2003;42:126-32.
109. Kobashigawa JA, Leaf DA, Lee N, Gleeson MP, Liu H, Hamilton MA, et al. A controlled trial of exercise rehabilitation after heart transplantation. N Engl J Med 1999;340:272-7.
110. Ramsey SD, Patrick DL, Albert RK, Larson EB, Wood DE, Raghu G. The cost-effectiveness of lung transplantation. A pilot study. University of Washington Medical Center Lung Transplant Study Group. Chest 1995;108:1594-601.
111. The EuroQol Group. EuroQol - a new facility for the measurement of health-related quality of life. Health Policy 1990;16:199-208.
112. Brooks R. EuroQol: the current state of play. Health Policy 1996;37:53-72.
113. Dolan P. Modeling valuations for EuroQol health states. Med Care 1997;35:1095-108.
114. Ramsey SD, Patrick DL, Lewis S, Albert RK, Raghu G. Improvement in quality of life after lung transplantation: a preliminary study. The University of Washington Medical Center Lung Transplant Study Group. J Heart Lung Transplant 1995;14:870-7.
115. Gross CR, Savik K, Bolman RM, 3rd, Hertz MI. Long-term health status and quality of life outcomes of lung transplant recipients. Chest 1995;108:1587-93.
116. TenVergert EM, Essink-Bot ML, Geertsma A, van Enckevort PJ, de Boer WJ, van der Bij W. The effect of lung transplantation on health-related quality of life: a longitudinal study. Chest 1998;113:358-64. (Pubitemid 28110011)
117. van Den BJ, Geertsma A, van der BW, Koeter GH, de BW, Postma DS, et al. Bronchiolitis obliterans syndrome after lung transplantation and health-related quality of life. Am J Respir Crit Care Med 2000;161:1937-41.
118. Anyanwu AC, McGuire A, Rogers CA, Murday AJ. Assessment of quality of life in lung transplantation using a simple generic tool. Thorax 2001;56:218-22.
119. Limbos MM, Chan CK, Kesten S. Quality of life in female lung transplant candidates and recipients. Chest 1997;112:1165-74.
120. Cohen L, Littlefield C, Kelly P, Maurer J, Abbey S. Predictors of quality of life and adjustment after lung transplantation. Chest 1998;113:633-44. (Pubitemid 28130935)
121. MacNaughton KL, Rodrigue JR, Cicale M, Staples EM. Healthrelated quality of life and symptom frequency before and after lung transplantation. Clin Transplant 1998;12:320-3.
122. Lanuza DM, Lefaiver C, Mc Cabe M, Farcas GA, Garrity Jr E. Prospective study of functional status and quality of life before and after lung transplantation. Chest 2000;118:115-22.
123. Stavem K, Bjortuft O, Lund MB, Kongshaug K, Geiran O, Boe J. Health-related quality of life in lung transplant candidates and recipients. Respiration 2000;67:159-65.
124. De Vito Dabbs A, Dew MA, Stilley CS, Manzetti J, Zullo T, McCurry KR, et al. Psychosocial vulnerability, physical symptoms and physical impairment after lung and heart-lung transplantation. J Heart Lung Transplant 2003;22:1268-75.
125. Vermeulen KM, Groen H, van der Bij W, Erasmus ME, Koeter GH, TenVergert EM. The effect of bronchiolitis obliterans syndrome on health related quality of life. Clin Transplant 2004;18:377-83.
126. Gerbase MW, Spiliopoulos A, Rochat T, Archinard M, Nicod LP. Health-related quality of life following single or bilateral lung transplantation: a 7-year comparison to functional outcome. Chest 2005;128:1371-8.
127. Gerbase MW, Soccal PM, Spiliopoulos A, Nicod LP, Rochat T. Long-term health-related quality of life and walking capacity of lung recipients with and without bronchiolitis obliterans syndrome. J Heart Lung Transplant 2008;27:898-904.
128. Girard F, Chouinard P, Boudreault D, Poirier C, Richard C, Ruel M, et al. Prevalence and impact of pain on the quality of life of lung transplant recipients: a prospective observational study. Chest 2006;130:1535-40.
129. Kugler C, Fischer S, Gottlieb J, Welte T, Simon A, Haverich A, et al. Health-related quality of life in two hundredeighty lung transplant recipients. J Heart Lung Transplant 2005;24:2262-8.
130. Rodrigue JR, Baz MA. Are there sex differences in healthrelated quality of life after lung transplantation for chronic obstructive pulmonary disease? J Heart Lung Transplant 2006;25(1):120-5.
131. Rodrigue JR, Baz MA, Kanasky Jr WF, MacNaughton KL. Does lung transplantation improve health-related quality of life? The University of Florida experience. J Heart Lung Transplant 2005;24:755-63.
132. Smeritschnig B, Jaksch P, Kocher A, Seebacher G, Aigner C, Mazhar S, et al. Quality of life after lung transplantation: a cross-sectional study. J Heart Lung Transplant 2005;24:474-80.
133. Vermeulen KM, TenVergert EM, Verschuuren EA, Erasmus ME, van der Bij W. Pre-transplant quality of life does not predict survival after lung transplantation. J Heart Lung Transplant 2008;27:623-7.
134. Vermuelen KM, van der Bij W, Erasmus ME, TenVergert EM. Long-term health-related quality of life after lung transplantation: different predictors for different dimensions. J Heart Lung Transplant 2007;26:188-93.
135. Limbos MM, Joyce DP, Chan CK, Kesten S. Psychological functioning and quality of life in lung transplant candidates and recipients. Chest 2000;118:408-16.
136. Von Neumann J, Morgenstern O. In: ED R, editor. Theory of games and economic behavior. New York: Wiley; 1953.
137. Nease Jr RF, Kneeland T, O'Connor GT, Sumner W, Lumpkins C, Shaw L, et al. Variation in patient utilities for outcomes of the management of chronic stable angina. Implications for clinical practice guidelines. Ischemic Heart Disease Patient Outcomes Research Team. JAMA 1995;273:1185-90.
138. Yusen R. What outcomes should be measured in patients with COPD? Chest 2001;119:327-8.
139. Al MJ, Koopmanschap MA, van Enckevort PJ, Geertsma A, van der Bij W, de Boer WJ, et al. Cost-effectiveness of lung transplantation in The Netherlands: a scenario analysis. Chest 1998;113:124-30.
140. Anyanwu AC, McGuire A, Rogers CA, Murday AJ. An economic evaluation of lung transplantation. J Thorac Cardiovasc Surg 2002;123:411-8 [discussion 8-20].
141. Gartner SH, Sevick MA, Keenan RJ, Chen GJ. Cost-utility of lung transplantation: a pilot study. J Heart Lung Transplant 1997;16:1129-34.
142. van Enckevort PJ, Koopmanschap MA, Tenvergert EM, Geertsma A, van der Bij W, de Boer WJ, et al. Lifetime costs of lung transplantation: estimation of incremental costs. Health Econ 1997;6:479-89.
143. Vasiliadis HM, Collet JP, Penrod JR, Ferraro P, Poirier C. A costeffectiveness and cost-utility study of lung transplantation. J Heart Lung Transplant 2005;24:1275-83.
144. Hoogendoorn M, Rutten-van Molken MP, Hoogenveen RT, van Genugten ML, Buist AS, Wouters EF, et al. A dynamic population model of disease progression in COPD. Eur Respir J 2005;26:223-33.
145. Groen H, van der Bij W, Koeter GH, TenVergert EM. Cost-effectiveness of lung transplantation in relation to type of end-stage pulmonary disease. Am J Transplant 2004;4:1155-62.